Langton-Hewer R, Miller S. Assessment of recovery of arm control in hemiplegic stroke patients. I. Arm function test. Int Rehabil Med 1980; 2: 3-9.
9. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spasticity [Monografía en línea]. Alemania: Clinical Department of Neurological Rehabilitation; 2009. [accesado 10 de marzo del 2013]; Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19197564
10. rozo al, jiménez juliao a. medida da independência funcional com escala fim nos pacientes com evento cérebro vascular do hospital militar central de bogotá no período outubro 2010 – maio 2011. rev med. diciembre de 2013;21(2):34-42.
11. Erbguth F. Historical note on the therapeutic use of botulinum toxin in neurological disorders. J Neurol Neurosurg Psychiatry [Monografía en línea]. Alemania: Department of Neurology, University of Erlangen-Nuremberg; 2000. [accesado 20 de marzo del 2013]; Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737149/pdf/v069p00499.pdf
12. Devriese P. On the Discovery of Clostridiumbotulinum. J Hist Neurosci 1999;8:43-50.
13. Carruthers A. History of the clinical use of botulinum toxin A and B. Clin Dermatol 2003;21:469-72.
14. Koussoulakos S. Botulinum neurotoxin: the ugly duckling. [Monografía en línea]. Grecia: Department of Cell Biology and Biophysics, Faculty of Biology, N. & K. University of Athens [accesado 15 de abril del 2013]; Disponible en: http://www.karger.com/Article/Pdf/210545
15. Vivancos-Matellano F, Pascual-Pascual SI, Nardi-Vilardaga J, Miquel-Rodríguez F, De Miguel-León I, Martínez-Garre MC, et al. Guía del tratamiento integral de la espasticidad. Rev Neurol 2007; 45: 365-75.
16. Francisco GE. Botulinum toxin: dosing and dilution. Am J Phys Med Rehabil 2004; 83 (Suppl): S30-7.
17. Brashear A, Mayer NH, eds. Spasticity and other forms of muscle overactivity in the upper motor neuron syndrome. New York: We Move; 2008.
18. Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapists Interested in Neurology. Spasticity in adults: management using botulinum toxin. National guidelines. London: RCP; 2009.
19. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart Disease and Stroke Statistics—2014 Update A Report From the American Heart Association. Circulation. 21 de enero de 2014;129(3):e28-292
20. Garcia-Ruiz PJ. [Applications of botulinum toxin in Neurology]. Med Clínica. 7 de julio de 2013;141(1):33-6.
21. Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, et al. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Health Technol Assess Winch Engl. mayo de 2010;14(26):1-113, iii – iv.
22. Ghasemi M, Salari M, Khorvash F, Shaygannejad V. A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity. Int J Prev Med. mayo de 2013;4(Suppl 2):S147-58